Search

everythinglearnresearchcommunity

for

Search:↓

Avicennia Marina extract and avicequinone C can reduce hair loss hormone production and increase hair growth factors, suggesting they could be used to treat androgenic alopecia.

Women of child-bearing age with androgenic alopecia lose hair density, especially in certain areas, and their hair becomes thinner. They also lose more than twice as much hair as healthy women.

Androgens may worsen COVID-19 and hair loss could indicate the disease's severity.

Androgenetic alopecia is a long-term, immune-related disorder that starts during puberty due to androgen secretion, and it might be improved with iron tablets, platelet transfusion, and anti-inflammation therapy.

Genetic testing can help understand male pattern baldness.

Androgen receptors significantly affect hair loss in women with androgenetic alopecia.

Male pattern baldness involves genetics, hormones, and needs better treatments.

Male pattern hair loss could hint at androgens affecting COVID-19 severity.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

Androgens can both promote and prevent hair growth due to differences in gene expression in hair follicles.

Different women's hair and skin glands respond to hormones in varied ways, which can cause unwanted hair growth even with normal hormone levels, and more research is needed to treat this effectively.

Genes and hormones cause hair loss, with four genes contributing equally.

Hair loss from genetics and hormones can be treated with drugs or surgery.

TGF-β1 increases androgen receptor activity in hair loss, but Hic-5/ARA55 can counter this effect.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

Plant-based remedies may treat hair loss by reducing inflammation and improving insulin resistance.

Antiandrogen therapy helps treat genetic hair loss.

New hair loss treatments may include topical medications, injections, and improved transplant methods.

Mechanical stress contributes to hair loss in androgenetic alopecia.

Hair loss may link to weaker COVID-19 immunity, suggesting possible need for extra vaccine boost.

Balding and low testosterone increase risk of urinary stones.

Androgens play a key role in hair growth and disorders like baldness and excessive hairiness.

A specific pathway involving AR, miR-221, and IGF-1 plays a key role in causing common hair loss.

Noni fruit extract, specifically the FEA-3 sub-fraction, can increase hair growth and reduce baldness in male rabbits, potentially acting like common hair loss treatments.

The study found that androgen receptors in skin cells mainly affect the focal adhesion pathway and control the caveolin-1 gene, with implications for new treatments for related diseases.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Hair loss linked to kidney stones in people under 60.

Personalized treatments for hair loss focus on specific genetic and biological pathways.

EX104 shows promise in treating hair loss by promoting hair growth and improving scalp health.

Hair transplants can trigger a rare scarring hair loss that is hard to treat.